PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 53 filers reported holding PROQR THRAPEUTICS N V in Q4 2019. The put-call ratio across all filers is 1.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $67,000 | -89.8% | 73,790 | -10.4% | 0.00% | -85.7% |
| Q4 2021 | $660,000 | +10.0% | 82,338 | -9.2% | 0.01% | +16.7% |
| Q1 2021 | $600,000 | +59.6% | 90,714 | +1.3% | 0.01% | +50.0% |
| Q4 2020 | $376,000 | +22.9% | 89,562 | +40.1% | 0.00% | -20.0% |
| Q3 2020 | $306,000 | -26.1% | 63,947 | -6.2% | 0.01% | -16.7% |
| Q2 2020 | $414,000 | -7.2% | 68,166 | -12.0% | 0.01% | +100.0% |
| Q3 2019 | $446,000 | -39.7% | 77,479 | -4.8% | 0.00% | -40.0% |
| Q2 2019 | $740,000 | – | 81,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $3,095,172 | 4.09% |
| Privium Fund Management B.V. | 5,344,446 | $8,658,003 | 1.82% |
| DAFNA Capital Management LLC | 940,582 | $1,523,743 | 0.42% |
| Opaleye Management Inc. | 653,000 | $1,057,860 | 0.25% |
| Ikarian Capital, LLC | 472,625 | $765,653 | 0.12% |
| EcoR1 Capital, LLC | 2,980,016 | $4,827,626 | 0.12% |
| Monaco Asset Management SAM | 237,517 | $384,778 | 0.11% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $243 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $5,873,257 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 189,328 | $306,711 | 0.01% |